Clinical Nutrition, 38(4), 1747-1755
After two weeks, callus formation in BPC-157 treated animals was twice as large as controls
How do I reconstitute GHK-Cu
But in practice, and especially with regard to synthetic and recombinant peptide forms, there are some considerable potential safety concerns: Immunogenicity Most notably, per a 2020 assessment on therapeutic peptide safety, synthetic and recombinant peptides pose the risk of immunogenicity the ability of a substance to provoke an immune response.15 An immunogenicity-inducing peptide, when introduced to the body, would cause the bodys immune system to perceive the peptide not as a medication but as a threat
Limited evidence but reasonable to try given low risk
Step 4 Allow the Peptide to Dissolve Naturally After the bacteriostatic water has been added, allow the vial to sit undisturbed for several minutes